Matex International Limited (SG:M15)
SGX:M15
Top Page
Matex International Limited
(SGX:M15)
Select Model
Select Model
Rating:47Neutral
Price Target:
S$0.02
▲(10.00% Upside)
Action:N/ADate:10/26/25
The overall score of 47 reflects significant concerns in financial performance, with deep losses, declining revenue, and negative cash flows being the primary drags. Technical stability and low volatility offer some balance, but a negative P/E ratio underscores valuation risks.
Positive Factors
Leadership Strengthening
The appointment of a new Executive Director and CTO can enhance technical leadership and drive innovation, potentially improving product offerings and competitive positioning.
Negative Factors
Declining Revenue
Consistent revenue decline indicates challenges in maintaining market share and demand, potentially impacting long-term financial health and operational viability.
Read all positive and negative factors
Positive Factors
Negative Factors
Leadership Strengthening
The appointment of a new Executive Director and CTO can enhance technical leadership and drive innovation, potentially improving product offerings and competitive positioning.
Read all positive factors
Matex International Limited (M15) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$11.35M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)0.43
Revenue Growth-20.15%
EPS Growth-2.30%
CountrySG
Employees65
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding515,698,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)0.88
Price to Sales (P/S)1.14
P/FCF Ratio-2.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Matex International Limited Business Overview & Revenue Model
Company Description
Matex International Limited engages in the formulation, manufacture, and sale of specialty chemicals in Singapore, the People's Republic of China, and Malaysia. It offers dyestuffs, auxiliaries, textile chemicals, and optical brighteners, as well ...
How the Company Makes Money
Matex International Limited generates revenue through the sale of its specialty chemical products and solutions to various industries. The company's primary revenue streams include direct sales to textile manufacturers, partnerships with distribut...
Matex International Limited Financial Statement Overview
Summary
Income Statement
15
Very Negative
Balance Sheet
40
Negative
Cash Flow
25
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.06M | 7.00M | 7.35M | 14.59M | 20.93M | 24.63M |
| Gross Profit | 1.31M | 1.47M | 1.61M | 2.51M | 2.64M | 3.42M |
| EBITDA | -4.33M | -2.55M | -3.23M | 5.39M | -5.01M | -8.58M |
| Net Income | -3.53M | -2.65M | -3.31M | 7.27M | -4.93M | -6.38M |
Balance Sheet | ||||||
| Total Assets | 16.90M | 15.24M | 21.40M | 24.25M | 30.22M | 33.52M |
| Cash, Cash Equivalents and Short-Term Investments | 10.09M | 8.86M | 16.37M | 11.92M | 5.66M | 4.51M |
| Total Debt | 1.98M | 1.49M | 3.20M | 4.40M | 6.12M | 11.83M |
| Total Liabilities | 7.13M | 7.29M | 9.15M | 9.15M | 23.14M | 19.59M |
| Stockholders Equity | 11.02M | 9.05M | 12.70M | 14.88M | 7.80M | 12.53M |
Cash Flow | ||||||
| Free Cash Flow | -3.51M | -2.97M | -754.00K | -1.25M | -35.00K | -4.67M |
| Operating Cash Flow | -2.94M | -2.40M | -456.00K | -1.17M | 238.00K | -3.98M |
| Investing Cash Flow | -2.89M | -3.23M | 3.82M | 11.77M | -267.00K | -578.00K |
| Financing Cash Flow | 6.95M | -1.88M | 1.12M | -4.82M | 1.91M | 5.65M |
Matex International Limited Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.02
Negative
0.02
Negative
Market Momentum
>-0.01
Neutral
100.00
Negative
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:M15, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:M15.
Matex International Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | S$30.78M | 3.59 | 9.55% | 1.22% | 33.55% | 2595.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | S$14.41M | 14.28 | 3.08% | ― | -8.21% | ― | |
52 Neutral | S$37.21M | -1.60 | -19.55% | 0.92% | -7.45% | -480.22% | |
47 Neutral | S$11.35M | -2.24 | -31.32% | ― | -20.15% | -2.30% | |
44 Neutral | S$41.76M | -1.64 | -30.86% | ― | -2.43% | 52.80% |
* Basic Materials Sector Average
SG:M15
Matex International Limited
0.02
<0.01
15.79%
SG:C05
Chemical Industries Far East Ltd.
0.49
0.02
4.26%
SG:5DS
MegaChem Ltd.
0.43
0.04
11.84%
SG:5MD
Soon Lian Holdings Limited
0.29
0.13
79.25%
SG:C8R
Jiutian Chemical Group Limited
0.02
>-0.01
-4.55%
SG:N32
Nippecraft Limited
0.04
0.00
0.00%
Matex International Limited Corporate Events
Matex International Announces Board Re-designation
Nov 26, 2025
Matex International Limited, a company incorporated in Singapore, has announced a change in its Board of Directors. Mr. James Kho Chung Wah, currently an Independent Director, will be re-designated as the Independent Chairman of the Board effectiv...
Matex International Faces Significant Legal Expenditure Impact
Nov 17, 2025
Matex International Limited, a company incorporated in Singapore, has announced a significant legal expenditure of S$518,942.41 incurred over a 10-week period related to shareholder requisitions, lawsuits, and a settlement agreement. This expendit...
Matex International Faces Legal Demand Over Settlement Payments
Nov 11, 2025
Matex International Limited, a company incorporated in Singapore, has received a letter of demand from Dr Tan Pang Kee and Mr Tan Guan Liang regarding cessation payments due under a settlement agreement. The letter demands payment by 18 November 2...
Matex International Announces Major Board Reshuffle
Nov 6, 2025
Matex International Limited, a company incorporated in Singapore, has announced significant changes to its board and board committees, effective from November 5, 2025. The company appointed Mr. Chen Hongbo as the new CEO, while Dr. Danny Oh Beng T...
Matex International Plans EGM for Cessation Payments Approval
Nov 3, 2025
Matex International Limited has announced an update regarding its intended Extraordinary General Meeting (EGM) to seek shareholder approval for cessation payments to Dr Tan Pang Kee and Mr Tan Guan Liang. The Board plans to publish the notice for ...
Matex International Limited Announces Board Changes
Oct 16, 2025
Matex International Limited, a company incorporated in Singapore, has announced a change in its board of directors with the appointment of Dr. Liu Shen as Executive Director and Chief Technical Officer, effective from October 17, 2025. This appoin...
Matex International Limited Holds Extraordinary General Meeting
Oct 15, 2025
Matex International Limited held an Extraordinary General Meeting at the Suntec Singapore Convention Exhibition Centre. The meeting was briefly adjourned to await announcements to the Singapore Exchange Securities Trading Limited, after which it ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.